Breaking News Bar
updated: 6/20/2014 8:40 AM

Drug maker Shire rejects offer from AbbVie

hello
Success - Article sent! close
  • The Dublin-based drugmaker Shire said Friday it has rejected an unsolicited $46.2 billion offer from Lake Forest-based AbbVie Inc., arguing that it fundamentally undervalues the company and its prospects.

      The Dublin-based drugmaker Shire said Friday it has rejected an unsolicited $46.2 billion offer from Lake Forest-based AbbVie Inc., arguing that it fundamentally undervalues the company and its prospects.
    abbvie.com

 
Associated Press

The Dublin-based drugmaker Shire said Friday it has rejected an unsolicited $46.2 billion offer from North Chicago-based AbbVie Inc., arguing that it fundamentally undervalues the company and its prospects.

The company said in a statement Friday that U.S.-based AbbVie's proposal was for 20.44 pounds ($34.78) and 0.7988 shares per Shire share. That values Shire stock at 46.11 pounds each -- a 23 percent premium to its price of 37.38 pounds on Thursday.

Order Reprint Print Article
 
Interested in reusing this article?
Custom reprints are a powerful and strategic way to share your article with customers, employees and prospects.
The YGS Group provides digital and printed reprint services for Daily Herald. Complete the form to the right and a reprint consultant will contact you to discuss how you can reuse this article.
Need more information about reprints? Visit our Reprints Section for more details.

Contact information ( * required )

Success - request sent close

Based on the number of outstanding shares in the company, the deal values Shire at 27.1 billion pounds.

Besides the price, Shire PLC says its board also has concerns about company structure "as AbbVie would redomicile in the UK for tax purposes."

The offer comes at a time of intense speculation in the industry, as drugmakers look to grow or eliminate noncore assets while focusing on strengths.

Last month, Pfizer pulled the plug on a takeover offer for Anglo-Swedish AstraZeneca, amid intense political pressure to keep jobs in Britain.

Share this page
Comments ()
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the X in the upper right corner of the comment box. To find our more, read our FAQ.
    help here